The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Rock Regulatory News (GCG)

  • This share is currently suspended. It was suspended at a price of 3.05

Share Price Information for Golden Rock (GCG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.05
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.05
GCG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraising and Board Changes

23 Feb 2021 16:33

RNS Number : 0939Q
Golden Rock Global PLC
23 February 2021
 

RNS Announcement

Golden Rock Global Plc

("Golden Rock" or the "Company")

Fundraising and Board Changes

Golden Rock Global (LSE: GCG), a special purpose acquisition company incorporated in Jersey and formed to undertake one or more acquisitions of a target company or business in the fintech sector is pleased to announce a conditional subscription to raise gross proceeds of approximately £200,000.

Subscription

The Company has entered into conditional subscription agreements (the "Subscription Agreements") with two subscribers (the "Subscribers") pursuant to which the Company has conditionally agreed to issue and allot 3,175,000 new ordinary shares in aggregate ("Subscription Shares") at a price of £0.0625 each in the capital of the Company (the "Subscription Price") to the Subscribers to raise gross proceeds of approximately £200,000 (the "Subscription"). The new ordinary shares will rank pari passu with the Company's existing issued ordinary shares. The Company intends to allot and issue the Subscription Shares under its existing authorities on a non pre-emptive basis.

The Subscription is conditional on admission of the Subscription Shares to the Official List of the Financial Conduct Authority ("FCA") and to trading on the Main Market (Standard List) of the London Stock Exchange plc ("LSE") ("Admission") and due receipt of the subscription monies from the Subscribers, which are expected to be received within 10 days of the date of the Subscription Agreements having been entered into.

The Subscription Price represents a discount of 51.92 per cent. to the closing mid-price per ordinary share on 22 February 2021. On Admission, the Subscription Shares will represent approximately 16.5 per cent. of the ordinary share capital of the Company in issue.

Ross Andrews, the Company's Chairman, commented: "These new funds will provide much needed additional working capital for the Company, extending the period in which we are able to continue to seek an acquisition".

Warrants

The Company further announces that in connection with the Subscription, the Company has executed a warrant instrument constituting 4,055,000 warrants exercisable on a one for one basis into ordinary shares in the capital of the Company at an exercise price of £0.0625 per ordinary share and an exercise period of 2-years commencing on (and including) the date of grant (the "Warrants"). The Warrants are only capable of being exercised upon the Company undertaking a transaction or other corporate event the completion of which would require the publication of a prospectus.

The board of Directors (the "Board") has approved the grant of 3,175,000 Warrants to the Subscribers, 480,000 Warrants to Ross Andrews and 400,000 Warrants to John Croft.

Application for Admission

The Company will be making its application to admit the Subscription Shares to the Official List of the FCA and to trading on the Main Market (Standard List) of the LSE. Admission is expected to occur by 31 March 2021 at the latest.

Conditional on Admission, the Company's issued ordinary share capital will be 19,175,000 ordinary shares, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Board Changes

The Board further announces that Feng Chen and Bin ("Vivien") Shi have tendered their resignations as independent non-executive directors of the Company and they will leave the Board with immediate effect.

Mr Andrews commented: "We understand the reasons behind Feng's and Vivien's decisions to resign from the Board and I would like to thank both of them for their contributions during their period in office. On behalf of the Board, I would like to wish both of them every success in the future".

**ENDS**

Enquiries

Golden Rock Global plc

Ross Andrews, Chairman

+44 (0) 1534 733 401

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGZZVFGGMZM
12
Date   Source Headline
13th Dec 202312:54 pmRNSExtension of Debt facility
29th Sep 20237:00 amRNSHalf-year Report
17th Aug 20237:39 amRNSProposed Transaction and Suspension of Listing
17th Aug 20237:30 amRNSSuspension - Golden Rock Global plc
26th Jul 20239:44 amRNSHolding(s) in Company
20th Jul 20234:36 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFundraising and Broker Appointment
19th Jul 20237:00 amRNSUpdate on Potential Acquisition
28th Jun 20237:00 amRNSStmnt re Share Price Movement
12th Jun 20237:00 amRNSResult of AGM
28th Apr 20233:29 pmRNSAnnual Financial Report
5th Apr 20233:11 pmRNSRestoration of Trading
5th Dec 20227:00 amRNSIssue of Debt
18th Oct 20227:00 amRNSHalf-year Report
30th Sep 20223:46 pmRNSResult of AGM
14th Jun 20227:00 amRNSFinal Results
17th Nov 20217:40 amRNSStatement re. Suspension
16th Nov 20214:40 pmRNSSecond Price Monitoring Extn
16th Nov 20214:35 pmRNSPrice Monitoring Extension
16th Nov 20212:05 pmRNSSecond Price Monitoring Extn
16th Nov 20212:00 pmRNSPrice Monitoring Extension
15th Nov 202111:05 amRNSSecond Price Monitoring Extn
15th Nov 202111:00 amRNSPrice Monitoring Extension
12th Nov 20212:27 pmRNSHolding(s) in Company
26th Oct 20214:35 pmRNSHolding(s) in Company
27th Sep 20213:20 pmRNSHalf-year Report
20th Jul 202112:32 pmRNSResult of AGM
18th Jun 202110:30 amRNSNotice of AGM
7th May 20218:35 amRNSFinal Results
15th Apr 20212:06 pmRNSSecond Price Monitoring Extn
15th Apr 20212:01 pmRNSPrice Monitoring Extension
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20212:05 pmRNSSecond Price Monitoring Extn
12th Mar 20212:00 pmRNSPrice Monitoring Extension
12th Mar 202111:06 amRNSSecond Price Monitoring Extn
12th Mar 202111:00 amRNSPrice Monitoring Extension
10th Mar 20214:00 pmRNSUpdate to Fundraising and expected Admission Date
8th Mar 20212:06 pmRNSSecond Price Monitoring Extn
8th Mar 20212:00 pmRNSPrice Monitoring Extension
8th Mar 202111:06 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
5th Mar 20214:40 pmRNSSecond Price Monitoring Extn
5th Mar 20214:36 pmRNSPrice Monitoring Extension
5th Mar 20212:05 pmRNSSecond Price Monitoring Extn
5th Mar 20212:00 pmRNSPrice Monitoring Extension
23rd Feb 20214:33 pmRNSFundraising and Board Changes
10th Feb 202111:06 amRNSSecond Price Monitoring Extn
10th Feb 202111:00 amRNSPrice Monitoring Extension
10th Feb 20219:06 amRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.